{
  "webinars": [
    {
      "id": "fda-cder-fda-approval-of-bizengri-zenocutuzumab-zbco",
      "title": "FDA approval of Bizengri (zenocutuzumab-zbco)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-bizengri-zenocutuzumab-zbco-treatment-adults-advanced",
      "description": "FDA CDER training: FDA approval of Bizengri (zenocutuzumab-zbco). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-overview-of-our-role-regulating-and-approving-drugs",
      "title": "Overview of our role regulating and approving drugs",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/information-consumers-and-patients-drugs/overview-our-role-regulating-and-approving-drugs-video-series",
      "description": "FDA CDER training: Overview of our role regulating and approving drugs. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-7-things-to-know-about-drug-shortage-management",
      "title": "7 Things to Know About Drug Shortage Management",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/7-things-know-about-drug-shortage-management",
      "description": "FDA CDER training: 7 Things to Know About Drug Shortage Management. Topics: Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-enhertu",
      "title": "FDA approval of Enhertu",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-enhertu-fam-trastuzumab-deruxtecan-nxki-unresectable-or",
      "description": "FDA CDER training: FDA approval of Enhertu. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fdas-regulation-of-dietary-supplements-with-dr-cara-welch",
      "title": "FDA’s Regulation of Dietary Supplements with Dr. Cara Welch",
      "provider": "FDA CDER",
      "topics": [
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/fdas-regulation-dietary-supplements-dr-cara-welch",
      "description": "FDA CDER training: FDA’s Regulation of Dietary Supplements with Dr. Cara Welch. Topics: Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-need-for-artificial-intelligence-in-pharmacovigilance-with-dr-robert-ball",
      "title": "The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert Ball",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "artificial-intelligence"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/audio-transcript-need-artificial-intelligence-pharmacovigilance-dr-robert-ball",
      "description": "FDA CDER training: The Need for Artificial Intelligence in Pharmacovigilance with Dr. Robert Ball. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-antibiotics-know-when-and-how-to-use-them",
      "title": "Antibiotics: Know When and How to Use Them",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=ZE_1_3TRvIk",
      "description": "FDA CDER training: Antibiotics: Know When and How to Use Them. Topics: Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-tecelra-afamitresgene-autoleucel",
      "title": "FDA approval of Tecelra (afamitresgene autoleucel)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-tecelra-afamitresgene-autoleucel-unresectable-or-metastatic",
      "description": "FDA CDER training: FDA approval of Tecelra (afamitresgene autoleucel). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-understanding-drug-recalls-with-dr-ileana-elder",
      "title": "Understanding Drug Recalls with Dr. Ileana Elder",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/understanding-drug-recalls-dr-ileana-elder",
      "description": "FDA CDER training: Understanding Drug Recalls with Dr. Ileana Elder. Topics: Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-resource-guide-for-teaching-faculty",
      "title": "Resource Guide for Teaching Faculty",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/154936/download?attachment",
      "description": "FDA CDER training: Resource Guide for Teaching Faculty. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-utilizing-generic-drug-awareness-to-improve-patient-outcomes-with-dr-sarah-ibrahim",
      "title": "Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/utilizing-generic-drug-awareness-improve-patient-outcomes-dr-sarah-ibrahim",
      "description": "FDA CDER training: Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim. Topics: Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-retevmo",
      "title": "FDA approval of Retevmo",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-retevmo-selpercatinib-advanced-or-metastatic-ret-fusion",
      "description": "FDA CDER training: FDA approval of Retevmo. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-accidental-exposures-to-fentanyl-patches-continue-to-be-deadly-to-children",
      "title": "Accidental Exposures to Fentanyl Patches Continue to Be Deadly to Children",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/accidental-exposures-fentanyl-patches-continue-be-deadly-children?",
      "description": "FDA CDER training: Accidental Exposures to Fentanyl Patches Continue to Be Deadly to Children. Topics: Drug Regulatory Process; Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-should-you-give-kids-medicine-for-coughs-and-colds",
      "title": "Should You Give Kids Medicine for Coughs and Colds?",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "otc-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/should-you-give-kids-medicine-coughs-and-colds?",
      "description": "FDA CDER training: Should You Give Kids Medicine for Coughs and Colds?. Topics: Drug Regulatory Process; Drug Safety; OTC Drug Regulations",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-what-does-fda-approve-part-2",
      "title": "What Does FDA Approve? Part 2",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/what-does-fda-approve-part-2",
      "description": "FDA CDER training: What Does FDA Approve? Part 2. Topics: Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-is-it-really-fda-approved",
      "title": "Is It Really 'FDA Approved'?",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved",
      "description": "FDA CDER training: Is It Really 'FDA Approved'?. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-10-facts-about-what-fda-does-and-does-not-approve",
      "title": "10 Facts about What FDA Does and Does Not Approve",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/10-facts-about-what-fda-does-and-does-not-approve",
      "description": "FDA CDER training: 10 Facts about What FDA Does and Does Not Approve. Topics: CBD; Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-sunscreen-how-to-help-protect-your-skin-from-the-sun",
      "title": "Sunscreen: How to Help Protect Your Skin from the Sun",
      "provider": "FDA CDER",
      "topics": [
        "sunscreen"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/understanding-over-counter-medicines/sunscreen-how-help-protect-your-skin-sun",
      "description": "FDA CDER training: Sunscreen: How to Help Protect Your Skin from the Sun. Topics: Sunscreen",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-facts-about-sunscreen",
      "title": "Facts about Sunscreen",
      "provider": "FDA CDER",
      "topics": [
        "sunscreen"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/rumor-control/facts-about-sunscreen",
      "description": "FDA CDER training: Facts about Sunscreen. Topics: Sunscreen",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-medicamentos",
      "title": "Medicamentos",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/fda-en-espanol/articulos-para-el-consumidor/medicamentos",
      "description": "FDA CDER training: Medicamentos. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-datos-acerca-de-los-medicamentos-genericos",
      "title": "Datos acerca de los medicamentos genéricos",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/generic-drugs/datos-acerca-de-los-medicamentos-genericos",
      "description": "FDA CDER training: Datos acerca de los medicamentos genéricos. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-hechos-sobre-los-medicamentos-genericos",
      "title": "Hechos Sobre Los Medicamentos Genericos",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/75523/download",
      "description": "FDA CDER training: Hechos Sobre Los Medicamentos Genericos. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-medicamentos-genericos-preguntas-y-respuestas",
      "title": "Medicamentos Genéricos: Preguntas y Respuestas",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/generic-drugs/medicamentos-genericos-preguntas-y-respuestas",
      "description": "FDA CDER training: Medicamentos Genéricos: Preguntas y Respuestas. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-2024-pda-fda-joint-regulatory-conference",
      "title": "2024 PDA/ FDA Joint Regulatory Conference",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/2024-pda-fda-joint-regulatory-conference-09092024",
      "description": "FDA CDER training: 2024 PDA/ FDA Joint Regulatory Conference. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-complex-innovative-trial-design-meeting-program",
      "title": "Complex Innovative Trial Design Meeting Program",
      "provider": "FDA CDER",
      "topics": [
        "case-study",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/development-resources/complex-innovative-trial-design-meeting-program",
      "description": "FDA CDER training: Complex Innovative Trial Design Meeting Program. Topics: Case Study; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-ojemda-tovorafenib",
      "title": "FDA approval of Ojemda (tovorafenib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-ojemda-tovorafenib-relapsed-or-refractory-pediatric-low-grade",
      "description": "FDA CDER training: FDA approval of Ojemda (tovorafenib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-strength-in-numbers-increasing-cancer-awareness-while-decreasing-disparities",
      "title": "Conversations on Cancer—Strength in Numbers: Increasing Cancer Awareness While Decreasing Disparities",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "regulatory",
        "drug-development",
        "drug-safety",
        "minority-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=9ZpFs4J4jKo",
      "description": "FDA CDER training: Conversations on Cancer—Strength in Numbers: Increasing Cancer Awareness While Decreasing Disparities. Topics: Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Minority Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-odac-chronicles-the-past-present-and-future-of-oncology-advisory-committees",
      "title": "Conversations on Cancer: ODAC Chronicles - the Past, Present, and Future of Oncology Advisory Committees",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=MNZhNkt-xyo",
      "description": "FDA CDER training: Conversations on Cancer: ODAC Chronicles - the Past, Present, and Future of Oncology Advisory Committees. Topics: Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-considerations-for-drug-products-that-contain-nanomaterials",
      "title": "Considerations for Drug Products that Contain Nanomaterials",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/considerations-drug-products-contain-nanomaterials",
      "description": "FDA CDER training: Considerations for Drug Products that Contain Nanomaterials. Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-compounding-quality-center-of-excellence-engage-with-the-compounding-quality-center-of-excellence",
      "title": "Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/compounding-quality-center-excellence/compounding-quality-center-excellence-engage-compounding-quality-center-excellence",
      "description": "FDA CDER training: Compounding Quality Center of Excellence | Engage with the Compounding Quality Center of Excellence. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-opioid-use-disorder-new-biosimilar-black-family-cancer-awareness-week-more",
      "title": "Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "regulatory",
        "drug-development",
        "drug-safety",
        "opioids",
        "minority-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=GC3xR_NlXHk&t=13s",
      "description": "FDA CDER training: Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more. Topics: Biosimilars; Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Minority Health, Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-role-of-artificial-intelligence-in-clinical-trial-design-and-research-with-dr-elzarrad",
      "title": "The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "artificial-intelligence"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/role-artificial-intelligence-clinical-trial-design-and-research-dr-elzarrad",
      "description": "FDA CDER training: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-practitioners-guide-for-improving-oral-anticoagulant-use",
      "title": "Practitioners’ Guide for Improving Oral Anticoagulant Use",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://fdapaseanticoagulants.e-paga.com",
      "description": "FDA CDER training: Practitioners’ Guide for Improving Oral Anticoagulant Use. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-14th-annual-sentinel-initiative-public-workshop",
      "title": "14th Annual Sentinel Initiative Public Workshop",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://healthpolicy.duke.edu/events/sentinel14?utm_medium=email&utm_source=govdelivery",
      "description": "FDA CDER training: 14th Annual Sentinel Initiative Public Workshop. Topics: COVID-19; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-6-tip-offs-to-rip-offs-don-t-fall-for-health-fraud-scams",
      "title": "6 Tip-Offs to Rip-Offs: Don't Fall for Health Fraud Scams",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/6-tip-offs-rip-offs-dont-fall-health-fraud-scams",
      "description": "FDA CDER training: 6 Tip-Offs to Rip-Offs: Don't Fall for Health Fraud Scams. Topics: Drug Safety; Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-accelerating-access-to-critical-therapies-for-als",
      "title": "Accelerating Access to Critical Therapies for ALS",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/node/402504",
      "description": "FDA CDER training: Accelerating Access to Critical Therapies for ALS. Topics: Drug Development; Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-accelerating-rare-disease-cures-arc-program",
      "title": "Accelerating Rare disease Cures (ARC) Program",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "rare-diseases"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/accelerating-rare-disease-cures-arc-program",
      "description": "FDA CDER training: Accelerating Rare disease Cures (ARC) Program. Topics: Drug Development; Drug Regulatory Process; Rare Diseases",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-achieving-data-quality-and-integrity-in-maximum-containment-laboratories",
      "title": "Achieving Data Quality and Integrity in Maximum Containment Laboratories",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/emergency-preparedness-and-response/outreach-and-professional-development-activities/training-course-achieving-data-quality-and-integrity-maximum-containment-laboratories",
      "description": "FDA CDER training: Achieving Data Quality and Integrity in Maximum Containment Laboratories. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-advancing-generic-drug-development-translating-science-to-approval-2023",
      "title": "Advancing Generic Drug Development: Translating Science to Approval 2023",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/advancing-generic-drug-development-translating-science-approval-2023-09132023",
      "description": "FDA CDER training: Advancing Generic Drug Development: Translating Science to Approval 2023. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-advancing-regulatory-science-at-fda",
      "title": "Advancing Regulatory Science at FDA",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/science-research/science-and-research-special-topics/advancing-regulatory-science",
      "description": "FDA CDER training: Advancing Regulatory Science at FDA. Topics: Drug Development; Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-advancing-transparency-and-regulatory-science-activities-on-the-risk-evaluation-and-mitigation-strategy-rems",
      "title": "Advancing Transparency and Regulatory Science Activities on the Risk Evaluation and Mitigation Strategy (REMS)",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/advancing-transparency-and-regulatory-science-activities-risk-evaluation-and-mitigation-strategy",
      "description": "FDA CDER training: Advancing Transparency and Regulatory Science Activities on the Risk Evaluation and Mitigation Strategy (REMS). Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-adverse-events-associated-with-compounded-drugs-from-outsourcing-facilities",
      "title": "Adverse Events Associated with Compounded Drugs from Outsourcing Facilities",
      "provider": "FDA CDER",
      "topics": [
        "case-study",
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/audio-transcript-fda-compounding-incidents-program-adverse-events-associated-compounded-drugs",
      "description": "FDA CDER training: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities. Topics: Case Study; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-airflow",
      "title": "Airflow",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 240,
      "certificate_available": true,
      "certificate_process": "CE credits available: 4.0 credits",
      "ce_credits": 4.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1092860/",
      "description": "FDA CDER training: Airflow. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-application-of-artificial-intelligence-and-machine-learning-for-precision-medicine",
      "title": "Application of Artificial Intelligence and Machine Learning for Precision Medicine",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "artificial-intelligence"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/application-artificial-intelligence-and-machine-learning-precision-medicine-02172023",
      "description": "FDA CDER training: Application of Artificial Intelligence and Machine Learning for Precision Medicine. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-are-you-on-a-biologic-medication-what-you-need-to-know-about-biosimilar-treatment-options",
      "title": "Are you on a biologic medication? What you need to know about biosimilar treatment options",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/165656/download?attachment",
      "description": "FDA CDER training: Are you on a biologic medication? What you need to know about biosimilar treatment options. Topics: Biosimilars",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-areas-of-customer-need-for-outsourcing-facility-products",
      "title": "Areas of Customer Need for Outsourcing Facility Products",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/162167/download?attachment",
      "description": "FDA CDER training: Areas of Customer Need for Outsourcing Facility Products. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-aseptic-process-simulations-media-fills",
      "title": "Aseptic Process Simulations (Media Fills)",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 120,
      "certificate_available": true,
      "certificate_process": "CE credits available: 2.0 credits",
      "ce_credits": 2.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/fda/course/1100254/?utm_medium=email&utm_source=govdelivery",
      "description": "FDA CDER training: Aseptic Process Simulations (Media Fills). Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-besaferx-your-source-for-online-pharmacy-information",
      "title": "BeSafeRx: Your Source for Online Pharmacy Information",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/quick-tips-buying-medicines-over-internet/besaferx-your-source-online-pharmacy-information",
      "description": "FDA CDER training: BeSafeRx: Your Source for Online Pharmacy Information. Topics: Drug Safety: Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biological-products-biosimilars-products-and-interchangeable-biosimilar-products",
      "title": "Biological Products, Biosimilars Products, and Interchangeable Biosimilar Products",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/154911/download?attachment",
      "description": "FDA CDER training: Biological Products, Biosimilars Products, and Interchangeable Biosimilar Products. Topics: Biosimilars; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-and-interchangeable-biologics-more-treatment-choices",
      "title": "Biosimilar and Interchangeable Biologics: More Treatment Choices",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/biosimilar-and-interchangeable-biologics-more-treatment-choices",
      "description": "FDA CDER training: Biosimilar and Interchangeable Biologics: More Treatment Choices. Topics: Biosimilars",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-basics",
      "title": "Biosimilar Basics",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/166369/download",
      "description": "FDA CDER training: Biosimilar Basics. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-basics-for-patients",
      "title": "Biosimilar Basics for Patients",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/biosimilars-basics-patients",
      "description": "FDA CDER training: Biosimilar Basics for Patients. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-manufacturing-and-variation",
      "title": "Biosimilar Manufacturing and Variation",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/154913/download?attachment",
      "description": "FDA CDER training: Biosimilar Manufacturing and Variation. Topics: Biosimilars; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-medications-what-health-care-providers-need-to-know",
      "title": "Biosimilar Medications - What Health Care Providers Need to Know",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=nFapJglrLmQ&feature=youtu.be",
      "description": "FDA CDER training: Biosimilar Medications - What Health Care Providers Need to Know. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-medications-what-patients-need-to-know",
      "title": "Biosimilar Medications - What Patients Need to Know",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=s7-CH5zdhXs",
      "description": "FDA CDER training: Biosimilar Medications - What Patients Need to Know. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilar-regulatory-approval-pathway",
      "title": "Biosimilar Regulatory Approval Pathway",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/154914/download?attachment",
      "description": "FDA CDER training: Biosimilar Regulatory Approval Pathway. Topics: Biosimilars; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilares-lo-que-los-pacientes-con-diabetes-deben-saber",
      "title": "Biosimilares: Lo que los pacientes con diabetes deben saber",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/166373/download",
      "description": "FDA CDER training: Biosimilares: Lo que los pacientes con diabetes deben saber. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilares-lo-que-los-pacientes-deben-saber",
      "title": "Biosimilares: Lo que los pacientes deben saber",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/166374/download",
      "description": "FDA CDER training: Biosimilares: Lo que los pacientes deben saber. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-101-a-primer-for-your-practice",
      "title": "Biosimilars 101: A Primer for Your Practice",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "case-study",
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs",
        "medwatch",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 15,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.25 credits",
      "ce_credits": 0.25,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/973406",
      "description": "FDA CDER training: Biosimilars 101: A Primer for Your Practice. Topics: Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-102-interchangeability-extrapolation-and-immunogenicity-a-regulatory-process-primer-medscape-org",
      "title": "Biosimilars 102: Interchangeability, Extrapolation, and Immunogenicity - A Regulatory Process Primer (medscape.org)",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 15,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.25 credits",
      "ce_credits": 0.25,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/999867?ecd=suppd_fda_distr_mscpedu",
      "description": "FDA CDER training: Biosimilars 102: Interchangeability, Extrapolation, and Immunogenicity - A Regulatory Process Primer (medscape.org). Topics: Biosimilars; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-basics-infographic",
      "title": "Biosimilars Basics Infographic",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/130918/download?attachment",
      "description": "FDA CDER training: Biosimilars Basics Infographic. Topics: Biosimilars; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-curriculum-materials-for-health-care-degree-programs",
      "title": "Biosimilars Curriculum Materials for Health Care Degree Programs",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "case-study",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/curriculum-materials-health-care-degree-programs-biosimilars",
      "description": "FDA CDER training: Biosimilars Curriculum Materials for Health Care Degree Programs. Topics: Biosimilars; Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-in-the-real-world-perspectives-for-staying-within-the-scope-of-care",
      "title": "Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "case-study",
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/983483?ecd=par_fda_distr_mscpedu",
      "description": "FDA CDER training: Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care. Topics: Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-level-1-foundational-concepts",
      "title": "Biosimilars Level 1: Foundational Concepts",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "case-study",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/curriculum-materials-health-care-degree-programs-biosimilars",
      "description": "FDA CDER training: Biosimilars Level 1: Foundational Concepts. Topics: Biosimilars; Case Study Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-level-2-regulatory-and-scientific-concepts",
      "title": "Biosimilars Level 2: Regulatory and Scientific Concepts",
      "provider": "FDA CDER",
      "topics": [
        "case-study"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/curriculum-materials-health-care-degree-programs-biosimilars",
      "description": "FDA CDER training: Biosimilars Level 2: Regulatory and Scientific Concepts. Topics: Case Study",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-multimedia-education-materials",
      "title": "Biosimilars Multimedia Education Materials",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/multimedia-education-materials-biosimilars",
      "description": "FDA CDER training: Biosimilars Multimedia Education Materials. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-overview-for-health-care-professionals",
      "title": "Biosimilars Overview for Health Care Professionals",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/overview-health-care-professionals",
      "description": "FDA CDER training: Biosimilars Overview for Health Care Professionals. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-patient-materials",
      "title": "Biosimilars Patient Materials",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/biosimilars-basics-patients",
      "description": "FDA CDER training: Biosimilars Patient Materials. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-resources",
      "title": "Biosimilars Resources",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "case-study",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/therapeutic-biologics-applications-bla/biosimilars",
      "description": "FDA CDER training: Biosimilars Resources. Topics: Biosimilars; Case Study; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-videos",
      "title": "Biosimilars Videos",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "biosimilars",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/curriculum-materials-health-care-degree-programs-biosimilars",
      "description": "FDA CDER training: Biosimilars Videos. Topics: Drug Development; Biosimilars;  Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-a-review-of-scientific-regulatory-and-clinical-considerations-for-health-care-providers",
      "title": "Biosimilars: A Review of Scientific, Regulatory, and Clinical Considerations for Health Care Providers",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/biosimilars-review-scientific-regulatory-and-clinical-considerations-health-care-providers",
      "description": "FDA CDER training: Biosimilars: A Review of Scientific, Regulatory, and Clinical Considerations for Health Care Providers. Topics: Biosimilars; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-are-they-the-same-quality",
      "title": "Biosimilars: Are they the same quality?",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/161628/download?attachment",
      "description": "FDA CDER training: Biosimilars: Are they the same quality?. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-what-patients-need-to-know",
      "title": "Biosimilars: What Patients Need to Know",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/166334/download?attachment",
      "description": "FDA CDER training: Biosimilars: What Patients Need to Know. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimilars-what-patients-with-diabetes-need-to-know",
      "title": "Biosimilars: What Patients With Diabetes Need To Know",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/166335/download?attachment",
      "description": "FDA CDER training: Biosimilars: What Patients With Diabetes Need To Know. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-biosimillars-health-care-provider-materials",
      "title": "Biosimillars Health Care Provider Materials",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/multimedia-education-materials-biosimilars",
      "description": "FDA CDER training: Biosimillars Health Care Provider Materials. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-bridging-efficacy-and-safety-to-the-obese",
      "title": "Bridging Efficacy and Safety to the Obese",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "expanded-access",
        "medwatch",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/bridging-efficacy-and-safety-obese-considerations-and-scientific-approaches-11092022",
      "description": "FDA CDER training: Bridging Efficacy and Safety to the Obese. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; MedWatch; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-bringing-clinical-research-to-patients",
      "title": "Bringing Clinical Research to Patients",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/womens-health-events/bringing-clinical-research-patients",
      "description": "FDA CDER training: Bringing Clinical Research to Patients. Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-cannabis-and-cannabis-derived-products-for-healthcare-practitioners",
      "title": "Cannabis and Cannabis-Derived Products – For Healthcare Practitioners",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "cannabis"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/cannabis-and-cannabis-derived-products-healthcare-practitioners",
      "description": "FDA CDER training: Cannabis and Cannabis-Derived Products – For Healthcare Practitioners. Topics: Drug Regulatory Process; Drug Development; Drug Safety; Cannabidiol",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-cder-conversation-improving-medication-adherence-and-patient-experience-by-researching-patient-perceptions-of-generic-drug",
      "title": "CDER Conversation: Improving Medication Adherence and Patient Experience by Researching Patient Perceptions of Generic Drug",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-conversations/improving-medication-adherence-and-patient-experience-researching-patient-perceptions-generic-drugs",
      "description": "FDA CDER training: CDER Conversation: Improving Medication Adherence and Patient Experience by Researching Patient Perceptions of Generic Drug. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-cder-webinars",
      "title": "CDER Webinars",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "generic-drugs",
        "otc-drugs",
        "biosimilars",
        "drug-safety",
        "medwatch",
        "expanded-access",
        "cancer"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-webinars",
      "description": "FDA CDER training: CDER Webinars. Topics: Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND/Expanded Access; Cancer Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-cders-emerging-drug-safety-technology-meeting-program",
      "title": "CDER’s Emerging Drug Safety Technology Meeting Program",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "artificial-intelligence"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-conversations/cders-emerging-drug-safety-technology-meeting-program",
      "description": "FDA CDER training: CDER’s Emerging Drug Safety Technology Meeting Program. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-cleanroom-in-person-course",
      "title": "Cleanroom In-person Course",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 825,
      "certificate_available": true,
      "certificate_process": "CE credits available: 13.75 credits",
      "ce_credits": 13.75,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/nm/course/1122944/live-event",
      "description": "FDA CDER training: Cleanroom In-person Course. Topics: Compounding; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-clinical-trial-basics",
      "title": "Clinical Trial Basics",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "expanded-access",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/clinical-trial-basics",
      "description": "FDA CDER training: Clinical Trial Basics. Topics: Drug Regulatory Process; Drug Development; Drug Safety; IND/Expanded Access; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-clinical-trial-basics-with-dr-robert-temple",
      "title": "Clinical Trial Basics with Dr. Robert Temple",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "expanded-access",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/clinical-trial-basics",
      "description": "FDA CDER training: Clinical Trial Basics with Dr. Robert Temple. Topics: Drug Regulatory Process; Drug Development; Drug Safety; IND/Expanded Access; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-compounding-outsourcing-facilities-annual-study",
      "title": "Compounding Outsourcing Facilities Annual Study",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/compounding-quality-center-excellence/outsourcing-facilities-annual-study",
      "description": "FDA CDER training: Compounding Outsourcing Facilities Annual Study. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-compounding-quality-center-of-excellence-annual-conference-2023",
      "title": "Compounding Quality Center of Excellence Annual Conference 2023",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "compounding",
        "covid-19"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/human-drug-compounding/compounding-quality-center-excellence-annual-conference-09112023",
      "description": "FDA CDER training: Compounding Quality Center of Excellence Annual Conference 2023. Topics: Compounding, COVID-19, Drug Development, Drug Regulatory Process, Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-compounding-quality-center-of-excellence-virtual-conference",
      "title": "Compounding Quality Center of Excellence Virtual Conference",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/compounding-quality-center-excellence/compounding-quality-center-excellence-annual-conference",
      "description": "FDA CDER training: Compounding Quality Center of Excellence Virtual Conference. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conceptos-ba-sicos-sobre-los-biosimilares",
      "title": "Conceptos ba¡sicos sobre los biosimilares",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/166370/download",
      "description": "FDA CDER training: Conceptos ba¡sicos sobre los biosimilares. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversation-on-paxlovid-with-dr-john-farley",
      "title": "Conversation on Paxlovid with Dr. John Farley",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/conversation-paxlovid",
      "description": "FDA CDER training: Conversation on Paxlovid with Dr. John Farley. Topics: COVID-19; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-black-history-month-program-real-talk-our-stories-as-black-oncologists-at-the-fda",
      "title": "Conversations on Cancer, Black History Month Program: Real Talk: Our Stories as Black Oncologists at the FDA",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "minority-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-oncology-center-excellence-presents-conversations-cancer-black-history-month-program-real-talk",
      "description": "FDA CDER training: Conversations on Cancer, Black History Month Program: Real Talk: Our Stories as Black Oncologists at the FDA. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety, Minority Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-what-s-on-the-horizon-future-of-cancer-care",
      "title": "Conversations on Cancer: \"What's on the Horizon: Future of Cancer Care\"",
      "provider": "FDA CDER",
      "topics": [
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=A6bqXarhj90",
      "description": "FDA CDER training: Conversations on Cancer: \"What's on the Horizon: Future of Cancer Care\". Topics: Cancer Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-bringing-innovation-to-people-facing-cancer",
      "title": "Conversations on Cancer: Bringing Innovation to People Facing Cancer",
      "provider": "FDA CDER",
      "topics": [
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=LSySqh2z-_A",
      "description": "FDA CDER training: Conversations on Cancer: Bringing Innovation to People Facing Cancer. Topics: Cancer Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-cancer-disparities-in-appalachia",
      "title": "Conversations on Cancer: Cancer Disparities in Appalachia",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=_jAZzAMdWEg",
      "description": "FDA CDER training: Conversations on Cancer: Cancer Disparities in Appalachia. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-cancer-misinformation-truth-or-consequences",
      "title": "Conversations on Cancer: Cancer Misinformation: Truth or Consequences",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=iTbsxJ5ONLY",
      "description": "FDA CDER training: Conversations on Cancer: Cancer Misinformation: Truth or Consequences. Topics: Cancer Drugs, Drug Development, Drug Regulatory Process, Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-how-biotech-built-a-blockbuster-cancer-drug",
      "title": "Conversations on Cancer: How Biotech Built a Blockbuster Cancer Drug",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=8L9CYRlz87E",
      "description": "FDA CDER training: Conversations on Cancer: How Biotech Built a Blockbuster Cancer Drug. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-living-with-metastatic-breast-cancer",
      "title": "Conversations on Cancer: Living with Metastatic Breast Cancer",
      "provider": "FDA CDER",
      "topics": [
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=O_-n5fCAqzc&t",
      "description": "FDA CDER training: Conversations on Cancer: Living with Metastatic Breast Cancer. Topics: Cancer Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-national-black-family-cancer-awareness-week-engaging-the-generations",
      "title": "Conversations on Cancer: National Black Family Cancer Awareness Week, Engaging the Generations",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "minority-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=PK1zoRX7MhA",
      "description": "FDA CDER training: Conversations on Cancer: National Black Family Cancer Awareness Week, Engaging the Generations. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety, Minority Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-seasons-of-change-oncology-careers",
      "title": "Conversations on Cancer: Seasons of Change: Oncology Careers",
      "provider": "FDA CDER",
      "topics": [
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=2ElU8pw1A6U&feature=youtu.be",
      "description": "FDA CDER training: Conversations on Cancer: Seasons of Change: Oncology Careers. Topics: Cancer Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-conversations-on-cancer-transforming-patient-lives-by-therapeutic-and-regulatory-innovations",
      "title": "Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=7IWz_xhm194",
      "description": "FDA CDER training: Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-cure-id-a-tool-for-clinicians-to-report-new-uses-of-existing-drugs-with-heather-stone-and-dr-marco-schito",
      "title": "CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito",
      "provider": "FDA CDER",
      "topics": [
        "case-study",
        "covid-19",
        "drug-development",
        "regulatory",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/cure-id-tool-clinicians-report-new-uses-existing-drugs-heather-stone-and-dr-marco-schito",
      "description": "FDA CDER training: CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito. Topics: Case Study; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-development-and-u-s-regulation-of-preventative-vaccines",
      "title": "Development and U.S. Regulation of Preventative Vaccines",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/development-and-us-regulation-preventative-vaccines",
      "description": "FDA CDER training: Development and U.S. Regulation of Preventative Vaccines. Topics: Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-drug-approval-case-studies",
      "title": "Drug Approval Case Studies",
      "provider": "FDA CDER",
      "topics": [
        "case-study",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "expanded-access"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/training-and-continuing-education/cderlearn-training-and-education/drug-approval-case-studies",
      "description": "FDA CDER training: Drug Approval Case Studies. Topics: Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-drug-information-soundcast-in-clinical-oncology-d-i-s-c-o",
      "title": "Drug Information Soundcast in Clinical Oncology (D.I.S.C.O)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs",
        "medwatch",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/drug-information-soundcast-clinical-oncology-disco",
      "description": "FDA CDER training: Drug Information Soundcast in Clinical Oncology (D.I.S.C.O). Topics: Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-drug-shortages-with-cdr-emily-thakur",
      "title": "Drug Shortages with CDR Emily Thakur",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/drug-shortages-cdr-emily-thakur",
      "description": "FDA CDER training: Drug Shortages with CDR Emily Thakur. Topics: COVID-19; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-drug-shortages-root-causes-and-potential-solutions",
      "title": "Drug Shortages: Root Causes and Potential Solutions",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/drug-shortages-root-causes-and-potential-solutions",
      "description": "FDA CDER training: Drug Shortages: Root Causes and Potential Solutions. Topics: Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-environmental-monitoring-in-person-course",
      "title": "Environmental Monitoring In-person Course",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 915,
      "certificate_available": true,
      "certificate_process": "CE credits available: 15.25 credits",
      "ce_credits": 15.25,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/nm/course/1122536/live-event",
      "description": "FDA CDER training: Environmental Monitoring In-person Course. Topics: Compounding; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-equity-of-voices-video-series",
      "title": "Equity of Voices video series",
      "provider": "FDA CDER",
      "topics": [
        "case-study",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/enhance-equity-initiative/enhance-equity-voices",
      "description": "FDA CDER training: Equity of Voices video series. Topics: Case Study; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-expanded-access-with-dr-jacqueline-corrigan-curay",
      "title": "Expanded Access with Dr. Jacqueline Corrigan-Curay",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "expanded-access"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/expanded-access-dr-jacqueline-corrigan-curay",
      "description": "FDA CDER training: Expanded Access with Dr. Jacqueline Corrigan-Curay. Topics: Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-101-an-overview-of-fda-s-regulatory-review-and-research-activities",
      "title": "FDA 101: An Overview of FDA's Regulatory Review and Research Activities",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "expanded-access",
        "otc-drugs",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/what-we-do/fda-101-overview-fdas-regulatory-review-and-research-activities",
      "description": "FDA CDER training: FDA 101: An Overview of FDA's Regulatory Review and Research Activities. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; OTC Drug Regulations; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-adds-boxed-warning-for-increased-risk-of-severe-hypocalcemia-in-patients-with-advanced-chronic-kidney-disease-taking-osteoporosis-medicine-prolia-denosumab",
      "title": "FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-adds-boxed-warning-increased-risk-severe-hypocalcemia-patients-advanced-chronic-kidney-disease",
      "description": "FDA CDER training: FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab). Topics: Disease States; Drug Development; Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-augtyro-repotrectinib",
      "title": "FDA approval of Augtyro (repotrectinib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-augtyro-repotrectinib-locally-advanced-or-metastatic-ros1",
      "description": "FDA CDER training: FDA approval of Augtyro (repotrectinib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-epkinly-epcoritamab-bysp",
      "title": "FDA approval of Epkinly (epcoritamab-bysp)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-epkinly-epcoritamab-bysp-relapsed-or-refractory-diffuse-large-b",
      "description": "FDA CDER training: FDA approval of Epkinly (epcoritamab-bysp). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-fruzaqla-fruquintinib",
      "title": "FDA approval of Fruzaqla (fruquintinib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-fruzaqla-fruquintinib-adult-patients-metastatic-colorectal",
      "description": "FDA CDER training: FDA approval of Fruzaqla (fruquintinib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-jemperli-dostarlimab-gxly",
      "title": "FDA approval of Jemperli (dostarlimab-gxly)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-jemperli-dostarlimab-gxly-dmmr-endometrial-cancer",
      "description": "FDA CDER training: FDA approval of Jemperli (dostarlimab-gxly). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-keytruda-pembrolizumab",
      "title": "FDA approval of Keytruda (pembrolizumab)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-keytruda-pembrolizumab-adjuvant-treatment-non-small-cell-lung",
      "description": "FDA CDER training: FDA approval of Keytruda (pembrolizumab). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-lynparza-olaparib",
      "title": "FDA approval of Lynparza (Olaparib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-lynparza-olaparib-abiraterone-and-prednisone-brca-mutated",
      "description": "FDA CDER training: FDA approval of Lynparza (Olaparib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-ogsiveo-nirogacestat",
      "title": "FDA approval of OGSIVEO (nirogacestat)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-ogsiveo-nirogacestat-adult-patients-progressing-desmoid-tumors",
      "description": "FDA CDER training: FDA approval of OGSIVEO (nirogacestat). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-omisirge-omidubicel-onlv",
      "title": "FDA approval of Omisirge (omidubicel-onlv)",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-omisirge-omidubicel-onlv-reduce-time-neutrophil-recovery-and",
      "description": "FDA CDER training: FDA approval of Omisirge (omidubicel-onlv). Topics: Cancer Drugs, Drug Development, Drug Regulatory Process, Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-padcev-enfortumab-vedotin-ejfv-with-keytruda-pembrolizumab",
      "title": "FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-padcev-enfortumab-vedotin-ejfv-keytruda-pembrolizumab-locally",
      "description": "FDA CDER training: FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-polivy-polatuzumab-vedotin-piiq",
      "title": "FDA approval of Polivy (polatuzumab vedotin-piiq)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-polivy-polatuzumab-vedotin-piiq-previously-untreated-diffuse",
      "description": "FDA CDER training: FDA approval of Polivy (polatuzumab vedotin-piiq). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-tafinlar-dabrafenib-with-mekinist-trametinib-for-pediatric-patients-with-low-grade-glioma-with-a-braf-v600e-mutation",
      "title": "FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-tafinlar-dabrafenib-mekinist-trametinib-pediatric-patients-low",
      "description": "FDA CDER training: FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-tibsovo-ivosidenib",
      "title": "FDA approval of Tibsovo (ivosidenib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-tibsovo-ivosidenib-patients-relapsed-or-refractory",
      "description": "FDA CDER training: FDA approval of Tibsovo (ivosidenib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-trodelvy-sacituzumab-govitecan-hziy",
      "title": "FDA approval of Trodelvy (sacituzumab govitecan-hziy)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-trodelvy-sacituzumab-govitecan-hziy-hr-positive-breast-cancer",
      "description": "FDA CDER training: FDA approval of Trodelvy (sacituzumab govitecan-hziy). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-verzenio-abemaciclib",
      "title": "FDA approval of Verzenio (abemaciclib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-verzenio-abemaciclib-endocrine-therapy-patients-hr-positive",
      "description": "FDA CDER training: FDA approval of Verzenio (abemaciclib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-zynyz-retifanlimab-dlwr",
      "title": "FDA approval of Zynyz (retifanlimab-dlwr)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-zynyz-retifanlimab-dlwr-metastatic-or-recurrent-locally",
      "description": "FDA CDER training: FDA approval of Zynyz (retifanlimab-dlwr). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approvals-of-jaypirca-pirtobrutinib-and-orserdu-elacestrant",
      "title": "FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-jaypirca-pirtobrutinib-relapsed-or-refractory-mantle-cell",
      "description": "FDA CDER training: FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approvals-of-talvey-and-elrexfio",
      "title": "FDA approvals of Talvey and Elrexfio",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-talvey-talquetamab-tgvs-relapsed-or-refractory-multiple",
      "description": "FDA CDER training: FDA approvals of Talvey and Elrexfio. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approvals-of-tukysa-tucatinib",
      "title": "FDA approvals of Tukysa (tucatinib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-tukysa-tucatinib-trastuzumab-colorectal-cancer-and-brukinsa",
      "description": "FDA CDER training: FDA approvals of Tukysa (tucatinib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-d-i-s-c-o-burst-edition-retevmo-selpercatinib",
      "title": "FDA D.I.S.C.O. Burst Edition: Retevmo (selpercatinib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-retevmo-selpercatinib-advanced-or-metastatic-ret-fusion",
      "description": "FDA CDER training: FDA D.I.S.C.O. Burst Edition: Retevmo (selpercatinib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-drug-info-rounds",
      "title": "FDA Drug Info Rounds",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "medwatch",
        "expanded-access",
        "drug-development",
        "regulatory",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/information-health-care-professionals-drugs/fda-drug-info-rounds-video",
      "description": "FDA CDER training: FDA Drug Info Rounds. Topics: Drug Safety; MedWatch; IND/Expanded Access; Drug Development; Drug Regulatory Process; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-drug-safety-podcasts",
      "title": "FDA Drug Safety Podcasts",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-podcasts",
      "description": "FDA CDER training: FDA Drug Safety Podcasts. Topics: Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-grand-rounds",
      "title": "FDA Grand Rounds",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "regulatory",
        "drug-development",
        "drug-safety",
        "medwatch",
        "generic-drugs",
        "otc-drugs",
        "biosimilars",
        "expanded-access",
        "cancer",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/science-research/about-science-research-fda/fda-grand-rounds",
      "description": "FDA CDER training: FDA Grand Rounds. Topics: COVID-19; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND/Expanded Access; Cancer Drugs; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-health-playbook",
      "title": "FDA Health Playbook",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "otc-drugs",
        "medwatch",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/buying-using-medicine-safely/fda-health-playbook",
      "description": "FDA CDER training: FDA Health Playbook. Topics: Drug Safety; OTC Drug Regulations; MedWatch; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-insight",
      "title": "FDA Insight",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "covid-19",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "opioids",
        "womens-health",
        "otc-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-newsroom/fda-insight",
      "description": "FDA CDER training: FDA Insight. Topics: Compounding; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids; Women's Health; OTC Drug Regulations",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-medwatch-and-patient-safety",
      "title": "FDA MedWatch and Patient Safety",
      "provider": "FDA CDER",
      "topics": [
        "medwatch",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/medical-product-safety-educational-resources",
      "description": "FDA CDER training: FDA MedWatch and Patient Safety. Topics: MedWatch; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-office-of-clinical-pharmacology-and-international-society-of-pharmacometrics-isop-public-workshop-using-modeling-and-simulation-to-select-dosages-for-combination-therapies-and-new-indications",
      "title": "FDA Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "expanded-access"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-office-clinical-pharmacology-and-international-society-pharmacometrics-isop-public-workshop",
      "description": "FDA CDER training: FDA Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-overview-of-biosimilar-products",
      "title": "FDA Overview of Biosimilar Products",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.accessdata.fda.gov/cder/bio/course/framework/index.html",
      "description": "FDA CDER training: FDA Overview of Biosimilar Products. Topics: Biosimilars;Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-rare-disease-day-2023",
      "title": "FDA Rare Disease Day 2023",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "rare-diseases"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/public-meeting-fda-rare-disease-day-2023-02272023",
      "description": "FDA CDER training: FDA Rare Disease Day 2023. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Rare Diseases",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-regulation-and-quality-considerations-for-cannabis-and-cannabis-derived-compounds",
      "title": "FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "expanded-access",
        "cannabis"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/fda-regulation-and-quality-considerations-cannabis-and-cannabis-derived-compounds",
      "description": "FDA CDER training: FDA Regulation and Quality Considerations for Cannabis and Cannabis-Derived Compounds. Topics: Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access; Cannabidiol",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-review-and-approval-process-for-biosimilar-medications",
      "title": "FDA Review and Approval Process for Biosimilar Medications",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://youtu.be/_p9QrWM9yOE",
      "description": "FDA CDER training: FDA Review and Approval Process for Biosimilar Medications. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-takes-steps-to-decrease-barriers-for-overdose-reversal-agents-with-dr-marta-sokolowska",
      "title": "FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "otc-drugs"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/fda-takes-steps-decrease-barriers-overdose-reversal-agents-dr-marta-sokolowska",
      "description": "FDA CDER training: FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; OTC Drug Regulations",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-updates-prescribing-information-for-all-opioid-pain-medicines-to-provide-additional-guidance-for-safe-use",
      "title": "FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-updates-prescribing-information-all-opioid-pain-medicines-provide-additional-guidance-safe-use",
      "description": "FDA CDER training: FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use. Topics: Drug Regulatory Process; Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-updating-warnings-to-improve-safe-use-of-prescription-stimulants-used-to-treat-adhd-and-other-conditions",
      "title": "FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-updating-warnings-improve-safe-use-prescription-stimulants-used-treat-adhd-and-other-conditions",
      "description": "FDA CDER training: FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions. Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-warns-of-rare-but-serious-drug-reaction-to-the-antiseizure-medicines-levetiracetam-keppra-keppra-xr-elepsia-xr-spritam-and-clobazam-onfi-sympazan",
      "title": "FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-warns-rare-serious-drug-reaction-antiseizure-medicines-levetiracetam-keppra-keppra-xr-elepsia-xr",
      "description": "FDA CDER training: FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan). Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-cder-office-of-clinical-pharmacology-and-international-society-of-pharmacometrics-isop-public-workshop-using-modeling-and-simulation-to-evaluate-the-effects-of-intrinsic-and-extrinsic-factors",
      "title": "FDA/CDER Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Evaluate the Effects of Intrinsic and Extrinsic Factors",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fdacder-office-clinical-pharmacology-and-international-society-pharmacometrics-isop-public-workshop",
      "description": "FDA CDER training: FDA/CDER Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Evaluate the Effects of Intrinsic and Extrinsic Factors. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-s-biomarker-qualification-program",
      "title": "FDA's Biomarker Qualification Program",
      "provider": "FDA CDER",
      "topics": [
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biomarker-qualification-program/videos-and-podcasts-fdas-biomarker-qualification-program",
      "description": "FDA CDER training: FDA's Biomarker Qualification Program. Topics: Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-s-overdose-prevention-framework-with-dr-marta-sokolowska",
      "title": "FDA's Overdose Prevention Framework with Dr. Marta Sokolowska",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "medwatch",
        "opioids",
        "cancer"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/fdas-overdose-prevention-framework-dr-marta-sokolowska",
      "description": "FDA CDER training: FDA's Overdose Prevention Framework with Dr. Marta Sokolowska. Topics: Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-s-regulation-of-dietary-supplements-with-dr-cara-welch",
      "title": "FDA's Regulation of Dietary Supplements with Dr. Cara Welch",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/fdas-regulation-dietary-supplements-dr-cara-welch",
      "description": "FDA CDER training: FDA's Regulation of Dietary Supplements with Dr. Cara Welch. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-s-role-in-public-health-drug-efficacy-safety-quality-and-beyond",
      "title": "FDA's Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond",
      "provider": "FDA CDER",
      "topics": [
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://fdadrugregulations.e-paga.com/",
      "description": "FDA CDER training: FDA's Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond. Topics: Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-s-work-to-combat-the-covid-19-pandemic",
      "title": "FDA's Work to Combat the COVID-19 Pandemic",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/160998/download?attachment",
      "description": "FDA CDER training: FDA's Work to Combat the COVID-19 Pandemic. Topics: COVID-19; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-frequently-asked-questions-about-labeling-for-prescription-medicines",
      "title": "Frequently Asked Questions about Labeling for Prescription Medicines",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/frequently-asked-questions-about-labeling-prescription-medicines",
      "description": "FDA CDER training: Frequently Asked Questions about Labeling for Prescription Medicines. Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-gdufa-ii-videos-and-resources",
      "title": "GDUFA II Videos and Resources",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/industry/generic-drug-user-fee-amendments/gdufa-ii-videos-and-resources",
      "description": "FDA CDER training: GDUFA II Videos and Resources. Topics: Drug Development; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-generics-and-biosimilars",
      "title": "Generics and Biosimilars",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/154912/download?attachment",
      "description": "FDA CDER training: Generics and Biosimilars. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-generics-at-a-glance-with-dr-sarah-ibrahim",
      "title": "Generics-at-a-Glance with Dr. Sarah Ibrahim",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/generics-glance-dr-sarah-ibrahim",
      "description": "FDA CDER training: Generics-at-a-Glance with Dr. Sarah Ibrahim. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-health-equity-forum-podcast",
      "title": "Health Equity Forum Podcast",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "drug-development",
        "regulatory",
        "drug-safety",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/minority-health-and-health-equity/health-equity-forum-podcast",
      "description": "FDA CDER training: Health Equity Forum Podcast. Topics: COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-health-fraud-product-database",
      "title": "Health Fraud Product Database",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/health-fraud-scams/health-fraud-product-database",
      "description": "FDA CDER training: Health Fraud Product Database. Topics: Drug Safety; Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-health-fraud-scams",
      "title": "Health Fraud Scams",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/health-fraud-scams",
      "description": "FDA CDER training: Health Fraud Scams. Topics: Drug Safety: Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-how-fda-and-ismp-utilize-medication-error-reports-to-improve-drug-safety",
      "title": "How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/how-fda-and-ismp-utilize-medication-error-reports-improve-drug-safety",
      "description": "FDA CDER training: How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety. Topics: Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-how-to-avoid-medication-errors-with-pen-injectors",
      "title": "How to Avoid Medication Errors with Pen Injectors",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/how-avoid-medication-errors-pen-injectors",
      "description": "FDA CDER training: How to Avoid Medication Errors with Pen Injectors. Topics: Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-how-to-use-the-consumer-complaint-system-and-medwatch",
      "title": "How to Use the Consumer Complaint System and MedWatch",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/fda-101-how-use-consumer-complaint-system-and-medwatch",
      "description": "FDA CDER training: How to Use the Consumer Complaint System and MedWatch. Topics: Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-hyperemesis-gravidarum-new-research-and-insights",
      "title": "Hyperemesis Gravidarum: New Research and Insights",
      "provider": "FDA CDER",
      "topics": [
        "womens-health",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/womens-health-events/hyperemesis-gravidarum-new-research-and-insights",
      "description": "FDA CDER training: Hyperemesis Gravidarum: New Research and Insights. Topics: Women's Health; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-incorporating-biosimilars-into-the-management-of-patients-with-immunological-conditions",
      "title": "Incorporating Biosimilars Into the Management of Patients With Immunological Conditions",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "case-study",
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs",
        "medwatch",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/975295",
      "description": "FDA CDER training: Incorporating Biosimilars Into the Management of Patients With Immunological Conditions. Topics: Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-increasing-the-efficiency-of-biosimilar-development-programs",
      "title": "Increasing the Efficiency of Biosimilar Development Programs",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/fda-workshop-increasing-efficiency-biosimilar-development-programs-09192022",
      "description": "FDA CDER training: Increasing the Efficiency of Biosimilar Development Programs. Topics: Biosimilars;Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-increasing-the-efficiency-of-biosimilar-development-programs-2023",
      "title": "Increasing the Efficiency of Biosimilar Development Programs 2023",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/increasing-efficiency-biosimilar-development-programs-reevaluating-need-comparative-clinical",
      "description": "FDA CDER training: Increasing the Efficiency of Biosimilar Development Programs 2023. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-information-about-medications-for-opioid-use-disorder-moud",
      "title": "Information about Medications for Opioid Use Disorder (MOUD)",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud",
      "description": "FDA CDER training: Information about Medications for Opioid Use Disorder (MOUD). Topics: Drug Regulatory Process; Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-insanitary-conditions-and-sterility-assurance",
      "title": "Insanitary Conditions and Sterility Assurance",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 240,
      "certificate_available": true,
      "certificate_process": "CE credits available: 4.0 credits",
      "ce_credits": 4.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1092865/",
      "description": "FDA CDER training: Insanitary Conditions and Sterility Assurance. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-insights-about-the-fda-ema-parallel-scientific-advice-program-for-complex-generic-hybrid-drug-products",
      "title": "Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/insights-about-fdaema-parallel-scientific-advice-program-complex-generichybrid-drug-products",
      "description": "FDA CDER training: Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products. Topics: Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-interchangeable-biological-products",
      "title": "Interchangeable Biological Products",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/151094/download?attachment",
      "description": "FDA CDER training: Interchangeable Biological Products. Topics: Biosimilars",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-interchangeable-biosimilars",
      "title": "Interchangeable Biosimilars",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=i0IJg511J5Q",
      "description": "FDA CDER training: Interchangeable Biosimilars. Topics: Biosimilars",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-investigations-and-corrective-and-preventive-actions-capa-2023",
      "title": "Investigations and Corrective and Preventive Actions (CAPA) 2023",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 300,
      "certificate_available": true,
      "certificate_process": "CE credits available: 5.0 credits",
      "ce_credits": 5.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1092489/",
      "description": "FDA CDER training: Investigations and Corrective and Preventive Actions (CAPA) 2023. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-investigations-and-corrective-and-preventive-actions-capa-virtual-course-2024",
      "title": "Investigations and Corrective and Preventive Actions (CAPA) Virtual Course 2024",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "regulatory",
        "drug-development"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1105033/live-event",
      "description": "FDA CDER training: Investigations and Corrective and Preventive Actions (CAPA) Virtual Course 2024. Topics: Compounding; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-joint-us-fda-health-canada-ich-public-meeting",
      "title": "Joint US FDA - Health Canada ICH Public Meeting",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "expanded-access"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/joint-us-fda-health-canada-ich-public-meeting-02242023",
      "description": "FDA CDER training: Joint US FDA - Health Canada ICH Public Meeting. Topics: Drug Development; Drug Regulatory Process; Drug Safety; IND/Expanded Access",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-leveraging-health-literacy-and-patient-preferences-to-reduce-hypoglycemia-events-in-patients-with-type-2-diabetes",
      "title": "Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.accessdata.fda.gov/cder/diabetes/launch.html",
      "description": "FDA CDER training: Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes. Topics: Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-maximizing-benefits-and-minimizing-harms-from-antibiotics",
      "title": "Maximizing Benefits and Minimizing Harms from Antibiotics",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/science-research/advancing-regulatory-science/maximizing-benefits-and-minimizing-harms-antibiotics-scientific-regulatory-and-clinical",
      "description": "FDA CDER training: Maximizing Benefits and Minimizing Harms from Antibiotics. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-medical-extended-reality-applications-and-challenges",
      "title": "Medical Extended Reality: Applications and Challenges",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/science-research/fda-grand-rounds/fda-grand-rounds-medical-extended-reality-applications-and-challenges-11172022",
      "description": "FDA CDER training: Medical Extended Reality: Applications and Challenges. Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-medication-health-fraud-and-avoiding-medication-scams-with-cynthia-ng",
      "title": "Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "medwatch",
        "generic-drugs",
        "regulatory",
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/medication-health-fraud-and-avoiding-medication-scams-cynthia-ng",
      "description": "FDA CDER training: Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng. Topics: Drug Safety; MedWatch; Generic Drugs; Drug Regulatory Process, Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-medwatch-your-report-can-make-a-difference-with-dr-gerald-dal-pan",
      "title": "MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/medwatch-your-report-can-make-difference",
      "description": "FDA CDER training: MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-minority-health-and-health-equity-webinars",
      "title": "Minority Health and Health Equity Webinars",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "minority-health"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/minority-health-and-health-equity/webinars-and-presentations",
      "description": "FDA CDER training: Minority Health and Health Equity Webinars. Topics: Drug Development; Drug Regulatory Process; Drug Safety, Minority Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-naltrexone-injection-for-opioid-use-disorder-fda-s-efforts-to-reduce-medication-errors",
      "title": "Naltrexone Injection for Opioid Use Disorder - FDA's Efforts to Reduce Medication Errors",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "medwatch",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/fda-drug-topics-naltrexone-injection-opioid-use-disorder-fdas-efforts-reduce-medication-errors",
      "description": "FDA CDER training: Naltrexone Injection for Opioid Use Disorder - FDA's Efforts to Reduce Medication Errors. Topics: Drug Regulatory Process; Drug Safety; MedWatch; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-navigating-the-world-of-online-pharmacies-with-cdr-lysette-deshields",
      "title": "Navigating the World of Online Pharmacies with CDR Lysette Deshields",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "health-fraud"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/navigating-world-online-pharmacies-cdr-lysette-deshields",
      "description": "FDA CDER training: Navigating the World of Online Pharmacies with CDR Lysette Deshields. Topics: Drug Regulatory Process; Drug Safety; Health Fraud",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-omhhe-health-equity-forum-podcast-toward-improving-race-and-ethnicity-data-in-healthcare",
      "title": "OMHHE Health Equity Forum Podcast - Toward Improving Race and Ethnicity Data in Healthcare",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/node/407334",
      "description": "FDA CDER training: OMHHE Health Equity Forum Podcast - Toward Improving Race and Ethnicity Data in Healthcare. Topics: Drug Development; Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-oncology-drug-products-used-with-certain-in-vitro-diagnostic-tests-pilot-program",
      "title": "Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/node/408304",
      "description": "FDA CDER training: Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-opioid-and-nicotine-use-dependence-and-recovery-influences-of-sex",
      "title": "Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "medwatch",
        "opioids",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/node/377548",
      "description": "FDA CDER training: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-outsourcing-facility-guide",
      "title": "Outsourcing Facility Guide",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 105,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.75 credits",
      "ce_credits": 1.75,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1091111",
      "description": "FDA CDER training: Outsourcing Facility Guide. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-overcoming-reluctance-and-enhancing-biosimilar-adoption",
      "title": "Overcoming Reluctance and Enhancing Biosimilar Adoption",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/1000424?ecd=suppd_fda_distr_mscpedu",
      "description": "FDA CDER training: Overcoming Reluctance and Enhancing Biosimilar Adoption. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-overcoming-reluctance-and-enhancing-biosimilar-adoption-medscape",
      "title": "Overcoming Reluctance and Enhancing Biosimilar Adoption (Medscape)",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/1000424?ecd=suppd_fda_distr_mscpedu",
      "description": "FDA CDER training: Overcoming Reluctance and Enhancing Biosimilar Adoption (Medscape). Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-overview-of-expanded-access-ea-program-and-ea-erequest-site",
      "title": "Overview of Expanded Access (EA) Program and EA eRequest Site",
      "provider": "FDA CDER",
      "topics": [
        "expanded-access",
        "rare-diseases",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/node/400064",
      "description": "FDA CDER training: Overview of Expanded Access (EA) Program and EA eRequest Site. Topics: IND/Expanded Access; Rare Diseases; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-overview-of-fda-role-regulating-and-approving-drugs",
      "title": "Overview of FDA role regulating and approving drugs",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/information-consumers-and-patients-drugs/overview-our-role-regulating-and-approving-drugs-video-series",
      "description": "FDA CDER training: Overview of FDA role regulating and approving drugs. Topics: Drug Development; Drug Regulatory Process; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-an-overview-of-fdas-project-facilitate-oncology-expanded-access-program",
      "title": "An Overview of FDA’s Project Facilitate Oncology Expanded Access Program",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/overview-fdas-project-facilitate-oncology-expanded-access-program",
      "description": "FDA CDER training: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program. Topics: Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-pcos-revisited-diagnosis-management-and-future-needs",
      "title": "PCOS Revisited: Diagnosis, Management, and Future Needs",
      "provider": "FDA CDER",
      "topics": [
        "womens-health",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/womens-health-events/pcos-revisited-diagnosis-management-and-future-needs",
      "description": "FDA CDER training: PCOS Revisited: Diagnosis, Management, and Future Needs. Topics: Women's Health; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-personnel-gowning-in-sterile-drug-production",
      "title": "Personnel Gowning in Sterile Drug Production",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1100310/",
      "description": "FDA CDER training: Personnel Gowning in Sterile Drug Production. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-pregnancy-and-lactation-medication-information-for-the-healthcare-provider",
      "title": "Pregnancy and Lactation Medication Information for the Healthcare Provider",
      "provider": "FDA CDER",
      "topics": [
        "womens-health",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/pregnancy-and-lactation-medication-information-healthcare-provider-05112022",
      "description": "FDA CDER training: Pregnancy and Lactation Medication Information for the Healthcare Provider. Topics: Women's Health; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-prescribe-with-confidence",
      "title": "Prescribe with Confidence",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/drug-safety-and-availability/prescribe-confidence",
      "description": "FDA CDER training: Prescribe with Confidence. Topics: Drug Regulatory Process; Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-primary-care-providers-can-prescribe-with-confidence",
      "title": "Primary Care Providers Can Prescribe with Confidence",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/prescribe-confidence/primary-care-providers-can-prescribe-confidence",
      "description": "FDA CDER training: Primary Care Providers Can Prescribe with Confidence. Topics: Drug Regulatory Process; Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-process-validation-virtual-course",
      "title": "Process Validation Virtual Course",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "regulatory",
        "drug-development"
      ],
      "format": "live",
      "duration_min": 900,
      "certificate_available": true,
      "certificate_process": "CE credits available: 15.0 credits",
      "ce_credits": 15.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/nm/course/1123040/live-event",
      "description": "FDA CDER training: Process Validation Virtual Course. Topics: Compounding; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-public-meeting-fda-rare-disease-day-2024",
      "title": "Public meeting: FDA Rare Disease Day 2024",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "rare-diseases"
      ],
      "format": "on-demand",
      "duration_min": 285,
      "certificate_available": true,
      "certificate_process": "CE credits available: 4.75 credits",
      "ce_credits": 4.75,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/public-meeting-fda-rare-disease-day-2024-03012024",
      "description": "FDA CDER training: Public meeting: FDA Rare Disease Day 2024. Topics: Drug Regulatory Process; Drug Safety Rare Diseases",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-putting-the-patient-into-perspective-strategies-for-educating-patients-about-biosimilars",
      "title": "Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "case-study",
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs",
        "medwatch",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 15,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.25 credits",
      "ce_credits": 0.25,
      "date_added": "2025-07-01",
      "url": "https://www.medscape.org/viewarticle/979176",
      "description": "FDA CDER training: Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars. Topics: Biosimilars; Cancer Drugs; Case Study; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-q-a-with-fda-podcast",
      "title": "Q&A with FDA Podcast",
      "provider": "FDA CDER",
      "topics": [
        "covid-19",
        "regulatory",
        "drug-development",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/qa-fda-podcast",
      "description": "FDA CDER training: Q&A with FDA Podcast. Topics: COVID-19; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-quality-management-systems-virtual-course",
      "title": "Quality Management Systems Virtual Course",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "regulatory",
        "drug-development"
      ],
      "format": "live",
      "duration_min": 900,
      "certificate_available": true,
      "certificate_process": "CE credits available: 15.0 credits",
      "ce_credits": 15.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1102115/live-event",
      "description": "FDA CDER training: Quality Management Systems Virtual Course. Topics: Compounding; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-rare-diseases-challenges-and-progress-in-drug-development",
      "title": "Rare Diseases - Challenges and Progress in Drug Development",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "drug-safety",
        "rare-diseases"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/rare-diseases-challenges-and-progress-drug-development",
      "description": "FDA CDER training: Rare Diseases - Challenges and Progress in Drug Development. Topics: Drug Development; Drug Safety; Rare Diseases",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-readdi-for-the-next-pandemic",
      "title": "READDI for the next pandemic",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/science-research/advancing-regulatory-science/readdi-next-pandemic-11092023",
      "description": "FDA CDER training: READDI for the next pandemic. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-regulatory-framework-for-human-drug-compounding",
      "title": "Regulatory Framework for Human Drug Compounding",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 90,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.5 credits",
      "ce_credits": 1.5,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1089314/",
      "description": "FDA CDER training: Regulatory Framework for Human Drug Compounding. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-regulatory-science-at-cder-videos",
      "title": "Regulatory Science at CDER Videos",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/regulatory-science-action/dr-woodcock-regulatory-science",
      "description": "FDA CDER training: Regulatory Science at CDER Videos. Topics: Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-reporting-and-public-viewing-of-individual-case-safety-reports-icsrs",
      "title": "Reporting and Public Viewing of Individual Case Safety Reports (ICSRs)",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/reporting-and-public-viewing-individual-case-safety-reports-icsrs",
      "description": "FDA CDER training: Reporting and Public Viewing of Individual Case Safety Reports (ICSRs). Topics: Drug Regulatory Process; Drug Development; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-reporting-unlawful-sales-of-medical-products-on-the-internet",
      "title": "Reporting Unlawful Sales of Medical Products on the Internet",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/safety/report-problem-fda/reporting-unlawful-sales-medical-products-internet",
      "description": "FDA CDER training: Reporting Unlawful Sales of Medical Products on the Internet. Topics: Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-risk-evaluation-and-mitigation-strategies-rems-program-part-1",
      "title": "Risk Evaluation and Mitigation Strategies (REMS) Program Part 1",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/our-perspective/our-perspective-two-part-series-risk-evaluation-and-mitigation-strategies-rems-program",
      "description": "FDA CDER training: Risk Evaluation and Mitigation Strategies (REMS) Program Part 1. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-risk-evaluation-and-mitigation-strategies-rems-program-part-2",
      "title": "Risk Evaluation and Mitigation Strategies (REMS) Program Part 2",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/our-perspective/risk-evaluation-and-mitigation-strategies-rems",
      "description": "FDA CDER training: Risk Evaluation and Mitigation Strategies (REMS) Program Part 2. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-safe-opioid-disposal",
      "title": "Safe Opioid Disposal",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "medwatch",
        "generic-drugs",
        "cancer",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/safe-disposal-medicines/safe-opioid-disposal-remove-risk-outreach-toolkit",
      "description": "FDA CDER training: Safe Opioid Disposal. Topics: Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs;Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-safety-labeling-changes-for-leukotriene-receptor-antagonists-and-decisions-behind-a-boxed-warning",
      "title": "Safety Labeling Changes for Leukotriene Receptor Antagonists and Decisions Behind a Boxed Warning",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/node/397296",
      "description": "FDA CDER training: Safety Labeling Changes for Leukotriene Receptor Antagonists and Decisions Behind a Boxed Warning. Topics: Drug Regulatory Process; Drug Development; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-sbia-chronicles",
      "title": "SBIA Chronicles",
      "provider": "FDA CDER",
      "topics": [
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/cder-sbia-chronicles",
      "description": "FDA CDER training: SBIA Chronicles. Topics: Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-second-annual-fda-asco-workshop-on-getting-the-dosage-right",
      "title": "Second Annual FDA ASCO WORKSHOP on Getting the Dosage Right",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/second-annual-fda-asco-workshop-getting-dosage-right-september-6-7-2023-09062023",
      "description": "FDA CDER training: Second Annual FDA ASCO WORKSHOP on Getting the Dosage Right. Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-stability-and-beyond-use-dates",
      "title": "Stability and Beyond Use Dates",
      "provider": "FDA CDER",
      "topics": [
        "case-study",
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety",
        "medwatch",
        "case-study"
      ],
      "format": "on-demand",
      "duration_min": 240,
      "certificate_available": true,
      "certificate_process": "CE credits available: 4.0 credits",
      "ce_credits": 4.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1092078/details",
      "description": "FDA CDER training: Stability and Beyond Use Dates. Topics: Case Study; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch; Case Study",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-state-of-outsourcing-facility-sector-and-possibilities-for-the-future",
      "title": "State of Outsourcing Facility Sector and Possibilities for the Future",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/156346/download",
      "description": "FDA CDER training: State of Outsourcing Facility Sector and Possibilities for the Future. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-a-step-forward-in-the-treatment-of-opioid-and-alcohol-dependence-with-dr-iilun-murphy-and-dr-marta-sokolowska",
      "title": "A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/step-forward-treatment-opioid-and-alcohol-dependence-dr-iilun-murphy-and-dr-marta-sokolowska",
      "description": "FDA CDER training: A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska. Topics: Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-sterile-drug-compounding-in-person-course",
      "title": "Sterile Drug Compounding In-person Course",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 960,
      "certificate_available": true,
      "certificate_process": "CE credits available: 16.0 credits",
      "ce_credits": 16.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1116457/live-event",
      "description": "FDA CDER training: Sterile Drug Compounding In-person Course. Topics: Compounding; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-sterility-testing-common-misconceptions",
      "title": "Sterility Testing: Common Misconceptions",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 45,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.75 credits",
      "ce_credits": 0.75,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/fda/course/1104685/",
      "description": "FDA CDER training: Sterility Testing: Common Misconceptions. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-successes-and-opportunities-in-modeling-and-simulation-for-fda",
      "title": "Successes and Opportunities in Modeling and Simulation for FDA",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/science-research/about-science-research-fda/modeling-simulation-fda",
      "description": "FDA CDER training: Successes and Opportunities in Modeling and Simulation for FDA. Topics: Drug Development; Drug Regulatory Process",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-summary-report-for-biosimilars",
      "title": "Summary Report for Biosimilars",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/165710/download",
      "description": "FDA CDER training: Summary Report for Biosimilars. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-supplier-contractor-qualification-and-management",
      "title": "Supplier/Contractor Qualification and Management",
      "provider": "FDA CDER",
      "topics": [
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 240,
      "certificate_available": true,
      "certificate_process": "CE credits available: 4.0 credits",
      "ce_credits": 4.0,
      "date_added": "2025-07-01",
      "url": "https://www.train.org/main/course/1097624/",
      "description": "FDA CDER training: Supplier/Contractor Qualification and Management. Topics: Compounding; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-switching-between-biosimilars-and-their-reference-counterparts-with-dr-sarah-yim",
      "title": "Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/switching-between-biosimilars-and-their-reference-counterparts-dr-sarah-yim",
      "description": "FDA CDER training: Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-current-status-of-oral-phenylephrine-as-a-nasal-decongestant-with-dr-theresa-michele-and-dr-ilisa-bernstein",
      "title": "The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "otc-drugs"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/current-status-oral-phenylephrine-nasal-decongestant-dr-theresa-michele-and-dr-ilisa-bernstein",
      "description": "FDA CDER training: The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein. Topics: Drug Regulatory Process; Drug Safety; OTC Drug Regulations",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-fda-bad-ad-program-and-prescription-drug-promotion",
      "title": "The FDA Bad Ad Program and Prescription Drug Promotion",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.accessdata.fda.gov/cder/ba/",
      "description": "FDA CDER training: The FDA Bad Ad Program and Prescription Drug Promotion. Topics: Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-fda-process-for-approving-generic-drugs",
      "title": "The FDA Process for Approving Generic Drugs",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "generic-drugs"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/training-and-continuing-education/cderlearn/online-training-seminar-fda-process-approving-generic-drugs",
      "description": "FDA CDER training: The FDA Process for Approving Generic Drugs. Topics: Drug Regulatory Process; Drug Development; Generic Drugs",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-future-of-clinical-trials-the-real-cost-campaign-and-sun-safety-tips",
      "title": "The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=QKAjyyvGx90",
      "description": "FDA CDER training: The Future of Clinical Trials, The Real Cost Campaign, and Sun Safety Tips. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Suncreen",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-role-of-pharmacodynamic-biomarkers-in-biosimilar-drug-development",
      "title": "The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/role-pharmacodynamic-biomarkers-biosimilar-drug-development",
      "description": "FDA CDER training: The Role of Pharmacodynamic Biomarkers in Biosimilar Drug Development. Topics: Biosimilars; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-the-safety-evaluation-and-surveillance-of-generic-drugs",
      "title": "The Safety Evaluation and Surveillance of Generic Drugs",
      "provider": "FDA CDER",
      "topics": [
        "generic-drugs",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 90,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.5 credits",
      "ce_credits": 1.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/safety-evaluation-and-surveillance-generic-drugs",
      "description": "FDA CDER training: The Safety Evaluation and Surveillance of Generic Drugs. Topics: Generic Drugs; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-topics-in-public-health",
      "title": "Topics in Public Health",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "case-study",
        "compounding",
        "covid-19",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "expanded-access",
        "medwatch",
        "opioids",
        "otc-drugs",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/training-and-continuing-education/fda-continuing-education-programs/topics-public-health",
      "description": "FDA CDER training: Topics in Public Health. Topics: Biosimilars; Cancer Drugs; Case Study; Compounding; COVID-19; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND/Expanded Access; MedWatch; Opioids; OTC Drug Regulations; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-treatment-using-medication-for-opioid-use-disorder-can-save-lives",
      "title": "Treatment Using Medication for Opioid Use Disorder Can Save Lives",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "opioids"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/news-events/fda-voices/treatment-using-medication-opioid-use-disorder-can-save-lives",
      "description": "FDA CDER training: Treatment Using Medication for Opioid Use Disorder Can Save Lives. Topics: Drug Regulatory Process; Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-understanding-generic-narrow-therapeutic-index-drugs",
      "title": "Understanding Generic Narrow Therapeutic Index Drugs",
      "provider": "FDA CDER",
      "topics": [
        "generic-drugs",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/understanding-generic-narrow-therapeutic-index-drugs",
      "description": "FDA CDER training: Understanding Generic Narrow Therapeutic Index Drugs. Topics: Generic Drugs; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-update-on-fdas-ongoing-evaluation-of-reports-of-suicidal-thoughts-or-actions-in-patients-taking-a-certain-type-of-medicines-approved-for-type-2-diabetes-and-obesity",
      "title": "Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 30,
      "certificate_available": true,
      "certificate_process": "CE credits available: 0.5 credits",
      "ce_credits": 0.5,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/fda-drug-safety-podcasts/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type",
      "description": "FDA CDER training: Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity. Topics: Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-update-on-fda-s-ongoing-evaluation-of-reports-of-suicidal-thoughts-or-actions-in-patients-taking-a-certain-type-of-medicines-approved-for-type-2-diabetes-and-obesity",
      "title": "Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "medwatch"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/drug-safety-and-availability/update-fdas-ongoing-evaluation-reports-suicidal-thoughts-or-actions-patients-taking-certain-type",
      "description": "FDA CDER training: Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity. Topics: Drug Development; Drug Regulatory Process; Drug Safety; MedWatch",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-using-bayesian-statistical-approaches-to-advance-our-ability-to-evaluate-drug-products",
      "title": "Using Bayesian Statistical Approaches to Advance our Ability to Evaluate Drug Products",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/using-bayesian-statistical-approaches-advance-our-ability-evaluate-drug-products",
      "description": "FDA CDER training: Using Bayesian Statistical Approaches to Advance our Ability to Evaluate Drug Products. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-what-does-fda-regulate",
      "title": "What does FDA regulate?",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-development",
        "drug-safety",
        "generic-drugs",
        "otc-drugs",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/what-we-do/what-does-fda-regulate",
      "description": "FDA CDER training: What does FDA regulate?. Topics: Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-what-is-a-biosimilar",
      "title": "What is a Biosimilar?",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/108905/download?attachment",
      "description": "FDA CDER training: What is a Biosimilar?. Topics: Biosimilars; Drug Regulatory Process; Drug Development",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-what-is-a-biosimilar-spanish",
      "title": "What is a Biosimilar? (Spanish)",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/media/142496/download?attachment",
      "description": "FDA CDER training: What is a Biosimilar? (Spanish). Topics: Biosimilars; Drug Regulatory Process; Drug Development; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-where-and-how-to-dispose-of-unused-medicines",
      "title": "Where and How to Dispose of Unused Medicines",
      "provider": "FDA CDER",
      "topics": [
        "drug-safety",
        "opioids"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/consumers/consumer-updates/where-and-how-dispose-unused-medicines",
      "description": "FDA CDER training: Where and How to Dispose of Unused Medicines. Topics: Drug Safety; Opioids",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-why-does-the-fda-exist",
      "title": "Why Does the FDA Exist?",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=DmYX23j5rnQ",
      "description": "FDA CDER training: Why Does the FDA Exist?. Topics: Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-drug-topics-webinars",
      "title": "FDA Drug Topics Webinars",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "cancer",
        "cannabis",
        "compounding",
        "drug-development",
        "regulatory",
        "drug-safety",
        "generic-drugs",
        "health-fraud",
        "expanded-access",
        "opioids",
        "rare-diseases"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": true,
      "certificate_process": "CE credits available: 1.0 credits",
      "ce_credits": 1.0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/about-fda/fda-pharmacy-student-experiential-program/fda-drug-topics-webinars",
      "description": "FDA CDER training: FDA Drug Topics Webinars. Topics: Biosimilars; Cancer Drugs; Cannabidiol; Compounding; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Health Fraud; IND/Expanded Access; Opioids; Rare Diseases",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approvals-of-augtyro-repotrectinib-and-krazati-adagrasib",
      "title": "FDA approvals of Augtyro (repotrectinib) and Krazati (adagrasib)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approvals-augtyro-repotrectinib-ntrk-gene-fusion-positive-solid-tumors",
      "description": "FDA CDER training: FDA approvals of Augtyro (repotrectinib) and Krazati (adagrasib). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-real-world-data-and-evidence-generation-with-dr-hilary-marston",
      "title": "Real-World Data and Evidence Generation with Dr. Hilary Marston",
      "provider": "FDA CDER",
      "topics": [
        "drug-development",
        "regulatory",
        "drug-safety",
        "artificial-intelligence"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/news-events-human-drugs/real-world-data-and-evidence-generation-dr-hilary-marston",
      "description": "FDA CDER training: Real-World Data and Evidence Generation with Dr. Hilary Marston. Topics: Drug Development; Drug Regulatory Process; Drug Safety; Artificial Intelligence",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-medicamentos-biosimilares-lo-que-los-pacientes-deben-saber",
      "title": "Medicamentos biosimilares: Lo que los pacientes deben saber",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=tpubWwLFCZY",
      "description": "FDA CDER training: Medicamentos biosimilares: Lo que los pacientes deben saber. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-what-is-accelerated-approval",
      "title": "What is Accelerated Approval?",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=GPZUPxgrrF4",
      "description": "FDA CDER training: What is Accelerated Approval?. Topics: Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-how-are-cancer-drugs-approved",
      "title": "How are Cancer Drugs Approved?",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=-nhR04mRCIY",
      "description": "FDA CDER training: How are Cancer Drugs Approved?. Topics: Cancer Drugs; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-adds-warning-about-rare-occurrence-of-serious-liver-injury-with-use-of-veozah-fezolinetant-for-hot-flashes-due-to-menopause",
      "title": "FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause",
      "provider": "FDA CDER",
      "topics": [
        "womens-health",
        "drug-safety"
      ],
      "format": "live",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due",
      "description": "FDA CDER training: FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause. Topics: Women's Health; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-curriculum-materials-for-health-care-degree-programs-biosimilars",
      "title": "Curriculum Materials for Health Care Degree Programs | Biosimilars",
      "provider": "FDA CDER",
      "topics": [
        "biosimilars",
        "regulatory",
        "drug-development",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/biosimilars/curriculum-materials-health-care-degree-programs-biosimilars",
      "description": "FDA CDER training: Curriculum Materials for Health Care Degree Programs | Biosimilars. Topics: Biosimilars; Drug Regulatory Process; Drug Development; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fdas-role-in-managing-drug-shortages",
      "title": "FDA’s Role In Managing Drug Shortages",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=ipIy2S6Zn0A",
      "description": "FDA CDER training: FDA’s Role In Managing Drug Shortages. Topics: Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-sepa-cuando-y-como-usar-antibioticos",
      "title": "Sepa cuándo y cómo usar antibióticos",
      "provider": "FDA CDER",
      "topics": [
        "regulatory",
        "drug-safety",
        "spanish"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/watch?v=puRHc_rT7y8",
      "description": "FDA CDER training: Sepa cuándo y cómo usar antibióticos. Topics: Drug Regulatory Process; Drug Safety; Español",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-oce-conversations-on-cancer-cervical-cancer-treatment-innovation-a-collaborative-discussion",
      "title": "OCE Conversations on Cancer, Cervical Cancer Treatment Innovation: A Collaborative Discussion",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "womens-health"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.youtube.com/live/DpL5se094EY",
      "description": "FDA CDER training: OCE Conversations on Cancer, Cervical Cancer Treatment Innovation: A Collaborative Discussion. Topics: Cancer Drugs; Drug Development; Women's Health",
      "live_date": "on-demand"
    },
    {
      "id": "fda-cder-fda-approval-of-ryoncil-remestemcel-l-rknd",
      "title": "FDA approval of Ryoncil (remestemcel-L-rknd)",
      "provider": "FDA CDER",
      "topics": [
        "cancer",
        "drug-development",
        "regulatory",
        "drug-safety"
      ],
      "format": "on-demand",
      "duration_min": 60,
      "certificate_available": false,
      "certificate_process": "No CE credits available",
      "ce_credits": 0,
      "date_added": "2025-07-01",
      "url": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-ryoncil-remestemcel-l-rknd-steroid-refractory-acute-graft",
      "description": "FDA CDER training: FDA approval of Ryoncil (remestemcel-L-rknd). Topics: Cancer Drugs; Drug Development; Drug Regulatory Process; Drug Safety",
      "live_date": "on-demand"
    },
    {
      "id": "pmi-on-demand-webinars",
      "title": "PMI On-Demand Webinars",
      "provider": "PMI",
      "topics": [
        "project-management"
      ],
      "format": "on-demand",
      "duration_min": "variable",
      "certificate_available": true,
      "certificate_process": "PDUs available upon completion",
      "date_added": "2025-07-01",
      "live_date": "on-demand",
      "url": "https://www.projectmanagement.com/webinars/webinarmainondemand.cfm",
      "description": "Access to PMI on-demand webinars. Free webinars available within the last 6 months. PDUs available upon completion."
    }
  ],
  "last_updated": "2025-07-01T21:48:51.161550",
  "total_count": 250
}